General Office of the General Administration of the people's Republic of China solicits guidance on the classification of generic drugs for conformity assessment of quality and efficacy
-
Last Update: 2016-11-30
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: CFDA 2016-11-30 announcement on the implementation of the opinions of the general office of the State Council on the quality and efficacy consistency evaluation of generic drugs (GBF [2016] No 8) and the opinions of the general office of the State Council on the quality and efficacy consistency evaluation of generic drugs (SFDA announcement) In 2016, No 106), the State Food and Drug Administration organized the drafting of the guidance on the classification of generic drugs for conformity assessment of quality and efficacy (Draft for comments), which is now open to the public for comments Please send the modification comments to the State Food and drug administration by email before December 31, 2016 E-mail: fzy@nifdc.org.cn Annex: Guidance on generic drug quality and efficacy conformity assessment category classification (Draft for comment) General Office of food and Drug Administration November 29, 2016 Annex: Guidance on generic drug quality and efficacy conformity assessment category classification (Draft for comment)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
